Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

348293

registered interest
date	03/06/2015
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Dangerous Dogs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, how many deaths and injuries have been caused by prohibited animals which are (a) not on and (b) on the Index of Exempted Dogs in each of the last five years.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	1007
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>There are no records held on the numbers of deaths or injuries caused by dogs held on the Index of Exempted Dogs. However, annual statistics for the last full five years, published by the Health &amp; Social Care Information Centre, on Counts of Finished Admission Episodes for dog bites and strikes is contained in the attached table (the figures should be read in conjunction with the footnotes to the table).</p><p> </p><p> </p><p> </p><p>In addition, the number of people killed by dogs each year for the last full five years is as follows:</p><p> </p><table><tbody><tr><td>2010</td><td>2</td></tr><tr><td>2011</td><td>0</td></tr><tr><td>2012</td><td>3</td></tr><tr><td>2013</td><td>4</td></tr><tr><td>2014</td><td>5</td></tr></tbody></table><p><br></p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p><strong>Counts of Finished Admission Episodes (FAEs)<sup>1</sup> for dog bites and strikes<sup>2</sup>, 2009-10 to 2013-14<sup>3</sup></strong></p><p> </p><p> </p><p> </p><p>Activity in English NHS Hospitals and English NHS commissioned activity in the independent sector</p><p> </p><table><tbody><tr><td><p><strong>Year</strong></p></td><td><p><strong>FAEs</strong></p></td></tr><tr><td><p>2009-10</p></td><td><p>5,837</p></td></tr><tr><td><p>2010-11</p></td><td><p>6,005</p></td></tr><tr><td><p>2011-12</p></td><td><p>6,580</p></td></tr><tr><td><p>2012-13</p></td><td><p>6,317</p></td></tr><tr><td><p>2013-14</p></td><td><p>6,836</p></td></tr></tbody></table><p> </p><p>Source: Hospital Episode Statistics (HES), Health and Social Care Information Centre</p><p> </p><p> </p><p> </p><p>1. Finished admission episodes A finished admission episode (FAE) is the first period of admitted patient care under one consultant within one healthcare provider. FAEs are counted against the year or month in which the admission episode finishes. Admissions do not represent the number of patients, as a person may have more than one admission within the period.</p><p> </p><p>2. External cause codes</p><p> </p><p>A supplementary code that indicates the nature of any external cause of injury, poisoning or other adverse effects. Only the first external cause code which is coded within the episode is counted in HES.</p><p> </p><p> </p><p> </p><p>ICD-10 code used: W54 - Bitten or struck by dog</p><p> </p><p> </p><p> </p><p>3. Assessing growth through time (Admitted patient care)</p><p> </p><p>HES figures are available from 1989-90 onwards. Changes to the figures over time need to be interpreted in the context of improvements in data quality and coverage (particularly in earlier years), improvements in coverage of independent sector activity (particularly from 2006-07) and changes in NHS practice. For example, apparent reductions in activity may be due to a number of procedures which may now be undertaken in outpatient settings and so no longer include in admitted patient HES data. Conversely, apparent increases in activity may be due to improved recording of diagnosis or procedure information.</p><p>Note that Hospital Episode Statistics (HES) include activity ending in the year in question and run from April to March, e.g. 2012-13 includes activity ending between 1st April 2012 and 31st March 2013.</p> answering member constituency Camborne and Redruth answering member printed George Eustice question first answered 08/06/2015 16:22:15 answering member 3934 label Biography information for George Eustice
tabling member	103 label Biography information for Sir Paul Beresford

348047

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hidradenitis Suppurativa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much the treatment of hidradenitis suppurativa cost the NHS in England in (a) 2012, (b) 2013 and (c) 2014.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	745
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>Hidradenitis suppurative (HS) affects around 90,000 people in England and can usually be managed with treatments including antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin.</p><p> </p><p> </p><p> </p><p>For those patients with the most serious forms of HS who cannot be managed through routine access treatments provided through primary or secondary care, a referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions and has set out what providers must have in place in order to offer specialist dermatology care. These services may provide more intensive therapies with a involvement of a range of health and care professionals, subject to that patient’s needs. More information can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p><p> </p><p> </p><p>The Department does not hold data on spending on individual dermatological conditions. However, the latest NHS Programme Budgeting data, which is for 2012-13, shows that the total spend on dermatology (excluding burns) was £1.98 billion.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 746 question first answered 08/06/2015 10:56:15 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

348048

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hidradenitis Suppurativa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to support patients with hidradenitis suppurativa.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	746
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>Hidradenitis suppurative (HS) affects around 90,000 people in England and can usually be managed with treatments including antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin.</p><p> </p><p> </p><p> </p><p>For those patients with the most serious forms of HS who cannot be managed through routine access treatments provided through primary or secondary care, a referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions and has set out what providers must have in place in order to offer specialist dermatology care. These services may provide more intensive therapies with a involvement of a range of health and care professionals, subject to that patient’s needs. More information can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p><p> </p><p> </p><p>The Department does not hold data on spending on individual dermatological conditions. However, the latest NHS Programme Budgeting data, which is for 2012-13, shows that the total spend on dermatology (excluding burns) was £1.98 billion.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 745 question first answered 08/06/2015 10:56:15 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

348049

registered interest
date	02/06/2015
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Social Security Benefits: Hidradenitis Suppurativa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, what training is provided to people who carry out assessments for employment and support allowance or personal independence payment on sufferers of hidradenitis suppurativa.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	747
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p /> <p>All healthcare professionals who carry out either Work Capability Assessments or Personal Independence Payment assessments undergo broad and thorough training in disability analysis, as well as training in specific conditions, including progressive conditions. Centre for Health and Disability Assessments, Atos Healthcare and Capita are required to conform to a rigorous set of quality and recruitment standards which are closely monitored by the Department for Work and Pensions.</p> answering member constituency Witham answering member printed Priti Patel question first answered 08/06/2015 09:58:24 answering member 4066 label Biography information for Priti Patel
tabling member	103 label Biography information for Sir Paul Beresford

225202

registered interest
date	04/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Shingles: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans he has to ensure the vaccination of eligible people who have not previously accessed the shingles vaccine.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	226309
answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>We are committed to delivering the Joint Committee on Vaccination and Immunisation’s (JCVI) recommendation on shingles immunisation. The vaccine is being offered routinely to those aged 70 years and to all those aged 71 to 79 years through a progressive catch-up.</p><p> </p><p> </p><p> </p><p>In the first year of the programme, 2013/14, the vaccine was offered to all those aged 70 and 79 years old. In 2014/15 the vaccine was offered to all those aged 70, 78 and 79 years old and in 2015/16, the vaccine will be offered to those aged 70 and 78 years old.</p><p> </p><p> </p><p> </p><p>General practitioners may also continue to offer immunisation to all those who have become eligible as 70 year olds from 1 September 2013 but have not yet been immunised.</p><p> </p><p> </p><p> </p><p>This progressive programme will ensure that all those JCVI has recommended be vaccinated will be offered the vaccine.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 226311 question first answered 09/03/2015 16:06:24 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

225203

registered interest
date	04/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Shingles: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether the shingles vaccination will be included as an indicator in the Public Health Outcomes Framework along with other recommended vaccination programmes.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	226310
answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>There will be a review of the Public Health Outcomes Framework later in 2015. Any proposal to include shingles vaccination as an indicator will be considered as part of the review process.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/03/2015 16:04:54 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

225204

registered interest
date	04/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Shingles: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when the Government plans to make the shingles vaccine available to everyone who requests it in the 70-79 age group.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	226311
answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>We are committed to delivering the Joint Committee on Vaccination and Immunisation’s (JCVI) recommendation on shingles immunisation. The vaccine is being offered routinely to those aged 70 years and to all those aged 71 to 79 years through a progressive catch-up.</p><p> </p><p> </p><p> </p><p>In the first year of the programme, 2013/14, the vaccine was offered to all those aged 70 and 79 years old. In 2014/15 the vaccine was offered to all those aged 70, 78 and 79 years old and in 2015/16, the vaccine will be offered to those aged 70 and 78 years old.</p><p> </p><p> </p><p> </p><p>General practitioners may also continue to offer immunisation to all those who have become eligible as 70 year olds from 1 September 2013 but have not yet been immunised.</p><p> </p><p> </p><p> </p><p>This progressive programme will ensure that all those JCVI has recommended be vaccinated will be offered the vaccine.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 226309 question first answered 09/03/2015 16:06:24 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

225205

registered interest
date	04/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Shingles: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the current shingles vaccination schedule is for 70 to 79 year olds; and if he will make a statement.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	226312
answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that shingles vaccine should be offered to all those aged 70 – 79 years. The vaccine is being routinely offered to all those aged 70 years and to all those aged 71 to 79 years through a progressive catch-up.</p><p> </p><p> </p><p> </p><p>In the first year of the programme, 2013/14, shingles vaccination was offered to patients aged 70 and 79 years old. For 2014/15, we are offering vaccination to patients aged 70, 78 and 79 years old and, for 2015/16, we will offer the vaccine to patients aged 70 and 78 years old.</p><p> </p><p> </p><p> </p><p>We are committed to delivering the JCVI’s recommendation in full. Eligibility criteria for immunisation in each year of the programme are informed by the volumes of vaccine that have been contracted and scheduled for delivery in that particular year.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/03/2015 15:54:49 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford